Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ari Raphael
29 years of experience
accreditations :
Clinic is certified :
Immunotherapy for lung cancer in Israel typically costs from $14,000 to $25,000. The total price depends on the drug type, dosage, and number of treatment cycles required. Patients save around 78% compared to the US, where this procedure costs $90,000 on average. Services in Tel Aviv and Ramat Gan often include oncologist consultations and specialized biomarker testing.
Bookimed Expert Insight: Choosing a multidisciplinary hub like Sourasky Medical Center (Ichilov) provides access to high-volume expertise. This facility treats 40,000 cancer patients annually with a 90% average success rate. Patients benefit from advanced diagnostics like Foundation One CDx genetic testing to personalize drug selection. Leading specialists often moderate national molecular tumor boards, ensuring treatment plans align with the latest global research.
| Israel | Turkey | Austria | |
| Immunotherapy for lung cancer | ≈ $14,000 | from $8,000 | ≈ $30,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for lung cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for lung cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for lung cancer journey.
Day 1 - Arrival
Day 2 - Pre-operation
Day 3 - Immunotherapy
Day 4 - Post-operation
Week 1 - Rehabilitation
Week 2 - Rehabilitation
Please keep in mind that each patient"s journey is unique and can vary. Always follow the specific advice provided by your medical team.
As the leading global medical tourism platform, Bookimed.com takes responsibility for providing reliable and accurate information to both patients and medical centers. Our platform offers information related to Immunotherapy for lung cancer and medical services in Israel. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there. Our experienced data scientist, who optimizes the ranking system using machine learning and artificial intelligence, collects data daily to ensure that the ranking system is up-to-date and provides accurate results for Immunotherapy for lung cancer in Israel.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients regarding their Immunotherapy for lung cancer treatment in Israel.
On Bookimed.com, you can find the best medical solutions from top medical service providers in Israel just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness for Immunotherapy for lung cancer treatment in Israel.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com regarding Immunotherapy for lung cancer treatment in Israel, please feel free to contact us at marketing@bookimed.com.
Leading researcher in lung cancer immunotherapy – Dr. Raphael pioneers T-cell repertoire sequencing studies at Sourasky Medical Center.
Prof. Merimsky heads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center with 41 years in lung cancer immunotherapy research and treatment.
Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.
Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.
Candidates for immunotherapy in Israel include patients with advanced solid tumors, relapsed blood cancers, or specific genetic markers like MSI-H/dMMR. Eligibility depends on PD-L1 expression levels and the absence of EGFR or ALK mutations, as confirmed by multidisciplinary tumor boards at JCI-accredited centers like Sourasky or Sheba.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center leverage the Foundation One CDx test to identify candidates beyond standard PD-L1 levels. This precision approach allows doctors like Dr. Ari Raphael to offer clinical trial access to patients who might be ineligible for immunotherapy in other regions due to less sensitive diagnostic tools.
Patient Consensus: Success depends heavily on personalized biomarker testing through blood or biopsy. Patients emphasize that while some achieve full remission, physical resilience is vital for protocols like TIL therapy available in Tel Aviv.
Immunotherapy for lung cancer in Israel achieves response rates up to 45% and disease control rates near 60% for non-small cell lung cancer. Leading institutions like Sourasky Medical Center and Sheba Medical Center utilize checkpoint inhibitors and molecular profiling to extend survival for advanced-stage patients.
Bookimed Expert Insight: Israeli oncology excels at converting non-responsive tumors through combination protocols. Clinics often pair immunotherapy with precision radiation using the Novalis TrueBeam STx. This synergy aims to trigger a stronger immune response than using drugs alone.
Patient Consensus: Patients emphasize the necessity of advanced molecular testing before starting treatment. Outcomes are often viewed as survival prolongation rather than a permanent cure for advanced stages.
Common side effects of immunotherapy include skin reactions, extreme fatigue, and flu-like symptoms. These immune-related adverse events occur because the treatment stimulates the immune system to attack healthy tissues. Most reactions appear within six months, though some may develop later or become chronic.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center utilize Foundation One CDx genetic testing to predict response. This molecular profiling helps specialists like Professor Ofer Merimsky tailor immunotherapy dosages. Individualized protocols may reduce the intensity of common side effects while maintaining high efficacy rates.
Patient Consensus: Fatigue is often the most persistent challenge, described as a deep exhaustion that rest cannot fix. Many patients recommend scheduling two days of recovery after each infusion to manage these energy drops.
Israel is a global leader in lung cancer immunotherapy, offering advanced immune checkpoint inhibitors and pioneering Tumor-Infiltrating Lymphocyte (TIL) therapy. Treatment is heavily biomarker-driven, utilizing Next-Generation Sequencing and PD-L1 testing to personalize protocols for non-small cell lung cancer (NSCLC) and extensive-stage small cell lung cancer.
Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky differentiate themselves by offering TIL therapy outside traditional clinical trials. This is a significant differentiator for Stage 4 patients who have exhausted standard checkpoint inhibitors. Our data shows these JCI-accredited facilities maintain high success rates by using multidisciplinary tumor boards to review every case.
Patient Consensus: Success depends heavily on pre-treatment PD-L1 testing and comprehensive mutation screening for EGFR or ALK. Patients emphasize distinguishing between general lung cancer protocols and specific T-cell therapies when contacting Israeli medical coordinators.
Immunotherapy for lung cancer typically lasts 2 years, often consisting of 35 treatment cycles. The duration varies based on clinical response, with maintenance therapy sometimes extending longer. Treatment may conclude earlier if scans show stable results or if side effects require a change in protocol.
Bookimed Expert Insight: Israel's leading oncology centers, like Sourasky Medical Center, utilize Foundation One CDx genomic profiling to tailor these timelines. Instead of a rigid 2-year window, specialists like Professor Ofer Merimsky use liquid biopsies to monitor real-time drug effectiveness. This precision approach helps determine if a patient can safely transition to a monitoring phase earlier or requires extended maintenance cycles.
Patient Consensus: Patients emphasize the importance of completing the full course even when experiencing fatigue. Many note that the immune system needs consistent time to effectively learn how to control cancer cells.
Israel utilizes advanced checkpoint inhibitors including Keytruda, Opdivo, Yervoy, and Tecentriq to treat lung, skin, and blood cancers. Specialized oncology centers like Sourasky Medical Center integrate these drugs with genetic profiling and liquid biopsies to personalize treatment protocols for international patients.
Bookimed Expert Insight: Israeli oncology excellence stems from combining immunotherapy with genomic medicine. Clinics like Sourasky use Foundation One CDx genetic testing to predict drug response. Dr. Ari Raphael even uses T-Cell Repertoire sequencing to track exactly how well a drug works for your specific immune system.
Patient Consensus: Patients emphasize that molecular mutation testing for markers like PD-L1 is vital before starting Keytruda. They recommend confirming marker status early as it directly determines which immunotherapy drug will be most effective.
Israel leads global oncology research through personalized immunotherapy, genomic profiling, and advanced clinical trials at Joint Commission International-accredited centers. Institutions like Sourasky Medical Center and Sheba Medical Center integrate translational research into clinical practice. They focus on checkpoint inhibitors and overcoming treatment resistance.
Bookimed Expert Insight: Israel's research landscape is uniquely interconnected between clinical and academic hubs. For instance, specialists like Dr. Ari Raphael lead the National Genomic Medicine Initiative while managing lung cancer boards. This means patients often access experimental protocols faster than in other regions. Top clinics maintain high volume, treating 40,000 cancer patients annually with a 90% success rate.
Patient Consensus: Patients value the early access to mRNA technologies and active genomic medicine projects like PSIFAS. Many emphasize the importance of distinguishing between blood cancer treatments and specific lung cancer immunotherapy applications.
Israel is a premier neurosurgery hub due to its fusion of high-density medical innovation and elite surgical expertise. Top facilities like Sheba Medical Center integrate AI-guided navigation and real-time intraoperative MRI. Specialized centers report 98% success rates for complex procedures including awake craniotomy and movement disorder treatments.
Bookimed Expert Insight: Data shows a clear divide between public and private options in Israel. Private centers like Assuta Medical Center perform over 92,000 operations annually and allow patients to select their specific lead surgeon. This is a vital advantage for complex cases where a specific expert like Dr. Eli Ashkenazi is preferred for his 1,000+ spine surgery record.
Patient Consensus: Patients emphasize bringing original imaging on a USB for local review to streamline the surgical plan. They also note that private packages often include hotel coordination and airport transfers, making the logistics much smoother.
Israeli neurosurgeons treat a full spectrum of conditions ranging from brain and spinal tumors to complex functional disorders. Specialized centers utilize advanced technologies like Gamma Knife, deep brain stimulation, and intraoperative MRI to manage epilepsy, Parkinson disease, and cerebrovascular pathologies with high precision.
Bookimed Expert Insight: Israeli hospitals often combine specialties to handle complex cases. At Sourasky Medical Center, neurosurgeons like Dr. Zvi Lidar bridge neurosurgery and orthopedics for spinal care. This multidisciplinary approach allows clinics to perform 34,000+ operations annually. Choosing a facility with this crossover expertise often leads to more comprehensive treatment plans for degenerative diseases.
Patient Consensus: Patients value the ability to access specialized treatments like fluorescence-guided surgery for tumors which are often unavailable elsewhere. Many note that the staff is fluent in English and provides clear communication through teleconsultations before traveling.
Israel is home to world-renowned neurosurgery centers like Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These facilities are globally ranked for treating complex brain tumors, spinal disorders, and movement diseases. They utilize advanced technologies like Gamma Knife, robotic systems, and intra-operative MRI.
Bookimed Expert Insight: Our data shows that while most patients focus on Tel Aviv, Rambam Medical Center in Haifa offers unique expertise in neuro-trauma. It operates a specialized neuro-ICU and serves nearly 1 million patients annually. This makes it an essential choice for complex post-trauma brain surgeries that requires intensive recovery support.
Patient Consensus: Patients note it is important to start consultations early. They often highlight that the precision and follow-up care for complex brain tumors exceeded their expectations. One patient emphasized how quickly they could connect with top professors for second opinions during critical neurosurgical cases.
Israel's leading neurosurgeons include Prof. Zvi Ram, Prof. Shlomi Constantini, and Prof. Itzhak Fried at Sourasky Medical Center. These specialists hold leadership roles in the European Association of Neurosurgical Societies (EANS) and the World Society for Stereotactic and Functional Neurosurgery (WSSFN). They utilize advanced intraoperative mapping and robotic systems.
Bookimed Expert Insight: Data from Sourasky and Sheba indicates a strong correlation between high surgical volumes and patient safety. For example, Sourasky performs 34,000+ operations annually with a 90% oncology success rate. Patients seeking complex tumor removals should prioritize centers like these where surgeons perform hundreds of specific cases each year.
Patient Consensus: Patients emphasize the importance of finding a surgeon who specializes specifically in your condition rather than a generalist. Many note that high-volume centers provide better access to English-speaking staff and coordinated care for international visitors.
International neurosurgery patients in Israel must provide comprehensive medical records including recent MRI or CT scans translated into English. Admission requires a clinical review by specialists to confirm treatment feasibility. Hospitals often mandate full advance payment or a significant deposit before confirming surgery dates or issuing visa support letters.
Bookimed Expert Insight: Data shows that top Israeli facilities like Sheba Medical Center and Hadassah Medical Center handle massive patient volumes, exceeding 1,000,000 people annually. This high demand means clinics prioritize complex or rare cases over routine procedures. Patients with unique or high-risk conditions often receive faster admission approval than those seeking standard treatments available elsewhere.
Patient Consensus: Patients note that having all imaging results ready in English is essential for quick scheduling. Many emphasize that while the medical care is excellent, coordinating around Shabbat closures is necessary to avoid unexpected diagnostic delays.
A standard stay for neurosurgery in Israel ranges from 10 to 14 days for uncomplicated cases. Patients undergoing complex procedures like brain tumor removal or deep brain stimulation often require 4 to 6 weeks. This timeline covers pre-operative diagnostics, the surgical procedure, and essential post-operative monitoring.
Bookimed Expert Insight: Data from Sourasky Medical Center shows they treat over 400,000 patients annually with high success rates. Clinics with such high volumes, like Hadassah or Assuta, often have streamlined discharge protocols. This helps international patients transition to hotel-based recovery faster while maintaining access to top specialists.
Patient Consensus: Patients note it is vital not to rush home too early. Some travelers extended their stay to 3 weeks due to swelling or to ensure they received final surgeon clearance before flying.
Israeli neurosurgery uses robotic guidance, real-time 3D imaging, and incisionless technologies to minimize physical trauma. Systems like Mazor Robotics provide sub-millimeter precision for spine implants. MRI-guided focused ultrasound (MRgFUS) treats tremors without incisions. These advanced tools ensure high accuracy and reduce recovery times.
Bookimed Expert Insight: Israeli clinics like Sourasky or Hadassah integrate proprietary Israeli-born technologies like Surgical Theater before they hit global markets. Our data shows these centers often use VR flight-through models for pre-surgical planning. This allows surgeons to rehearse complex cases, which is a key factor in their 90% success rates.
Patient Consensus: Patients note that technologies like the Gamma Knife allowed them to return home in days rather than weeks. Many move from traditional 10cm incisions to cuts under 2cm when using robotic-assisted systems.
Israel is a global leader in neurosurgery due to its integration of proprietary medical innovations and internationally trained specialists. High-capacity centers like Sourasky Medical Center (Ichilov) perform over 34,000 annual surgeries. Patients access advanced techniques like awake craniotomy and MR-guided focused ultrasound.
Bookimed Expert Insight: Israeli neurosurgery stands out because of the high concentration of dually certified experts. Many top surgeons, such as Dr. Zvi Lidar, are certified to practice in both Israel and the USA. This ensures that patients receive American-standard surgical care while staying in Tel Aviv or Jerusalem. Our data shows that private centers like Assuta offer significantly faster access to these specific specialists compared to the public system.
Patient Consensus: Patients note it is important to confirm a surgeon's specific volume of cases for your exact condition. They also value the ability to get expert second opinions quickly through online consultations with world-renowned professors.
Sheba Medical Center and Sourasky Medical Center (Ichilov) are among the best neurosurgery hospitals in Israel. These JCI-accredited facilities perform thousands of operations annually. They utilize advanced technologies like CyberKnife and intraoperative MRI to treat complex brain tumors and cerebrovascular lesions.
Bookimed Expert Insight: Our data shows that top Israeli centers like Sourasky and Hadassah perform over 40,000 total operations yearly. This high volume allows surgeons to maintain a 90% success rate even in complex oncology cases. Patients seeking robotic spine surgery or deep brain stimulation should focus on these high-capacity municipal centers for the most experienced teams.
Patient Consensus: Patients appreciate that some hospitals quickly coordinate consultations even during regional strikes. Families of pediatric patients especially value surgeons trained at prestigious international institutions.
Israel's leading neurosurgeons include Professor Zvi Ram, Professor Shlomi Constantini, and Professor Itzhak Fried at Sourasky Medical Center. These experts specialize in awake craniotomy, pediatric brain tumors, and functional mapping. Most hold JCI accreditation and international fellowships from institutions like Johns Hopkins and Yale.
Bookimed Expert Insight: Data shows that top-tier Israeli neurosurgeons, such as those at Sourasky Medical Center, often hold dual board certifications in Israel and the US. This unique crossover ensures patients receive American-standard protocols. These specialists typically manage over 34,000 annual operations, providing high-volume clinical experience that smaller private clinics cannot match.
Patient Consensus: Patients note that highly qualified doctors like Professor Shlomo Constantini provide satisfactory answers quickly. People emphasize that outcomes often depend on the hospital’s integrated resources rather than just a doctor's prestige.
Israel is a global leader in neurosurgery, treating complex brain and spinal conditions using robotic-assisted and minimally invasive techniques. Highly specialized units at JCI-accredited centers like Sourasky Medical Center (Ichilov) and Hadassah Medical Center focus on neuro-oncology, pediatric neurosurgery, and functional procedures.
Bookimed Expert Insight: Israeli neurosurgical departments often function as rapid-response hubs for international patients. Data shows that large centers like Sourasky, which serves 1,800,000 patients annually, can organize expert video consultations in a very short time. This speed is critical for neuro-oncology cases where starting treatment a few days earlier significantly impacts outcomes.
Patient Consensus: Patients note that Israeli teams often accept high-risk cases that other hospitals decline. They emphasize the importance of using local coordinators to manage travel logistics or potential local disruptions during their two-week stay.
International patients traveling to Israel for neurosurgery require a valid passport, an entry permit or medical visa, and a formal hospital invitation. You must provide recent MRI or CT scans in DICOM format and detailed medical summaries. Proof of private health insurance and financial stability are also mandatory for border entry.
Bookimed Expert Insight: Our data shows that top neurosurgeons at Hadassah Medical Center and Sourasky often request records 4–6 weeks before arrival. Submitting these early prevents appointment shifts. High-volume centers with over 30,000 annual operations have dedicated portals for secure DICOM file uploads. Using these ensures your surgeon reviews high-quality images before you land in Tel Aviv.
Patient Consensus: Patients emphasize bringing physical copies and digital backups of all scans on a USB drive. They also note that private insurance needs pre-authorization specifically for neurosurgery to avoid payment delays at the clinic.